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Parental involvement in paediatric cancer treatment decisions
This study investigated parents’ information needs and involvement in decision-making processes affecting
the care of children diagnosed with cancer. Interviews and questionnaires were used to assess parental
satisfaction in 50 mothers and 16 fathers responsible for 58 children in an English Paediatric Oncology Unit.
Parents reported that doctors contributed almost twice as much to the decision-making process as they did, but
parental satisfaction was positively correlated with the amount of information provided when giving informed
consent. Satisfaction about their involvement in this process relied heavily upon the level of support received
from others. Parents consenting to their child’s involvement in non-randomised trials perceived themselves to
be under greater pressure from others during the decision-making process while those whose children were
further along the treatment trajectory were more uncertain about decisions previously made. Findings indicate
that the accessibility, support, information and degree of control afforded to parents by healthcare professionals
impacts upon their satisfaction with both the decision-making process and their conﬁdence in the decisions
thus made. Information and support tailored to parents’ speciﬁc needs may therefore enhance satisfaction with
clinical decision making and reassure parents about decisions made in the long-term interest of their child’s
health.
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INTRODUCTION
Rapidly evolving developments in medical technology
have provided more options for the treatment of different
malignancies. As new medications are tested for their
effectiveness, more paediatric patients are recruited into
treatment programmes such as clinical trials (Smith et al.
1993; Van Stuijvenberg et al. 1998). Consequently, the
informed consent process has become a major issue in the
ﬁeld of paediatric oncology and the emphasis is shifting
towards ‘shared consent’ to provide parents with the
appropriate levels of information and support to assist
their participation in decision making (Van Stuijvenberg
et al. 1998; Massimo et al. 2004). To this end, partnership
research with parents of paediatric patients has been con-
ducted to improve the informed consent procedure (Eder
et al. 2007) and strategies are being developed to facilitate
the parental decision-making process (Tomlinson et al.
2006). Although research in this area is rapidly increasing,
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to participate in intensive treatments regimens (including
randomised clinical trials) and the residual effects of these
decisions have been limited. Current research shows a
range of factors associated with parental involvement in
decision making including their relationship with the
physician, the nature of physician–parent communica-
tion, trust, parents’ and physician’s knowledge and expe-
rience, and the perceived importance of the parental role
(Pyke-Grimm et al. 2006).
Early studies have shown that even though parents may
be generally satisﬁed with the handling of informed
consent by medical practitioners, parental decisions about
treatment are often made under high levels of stress (Ruc-
cione et al. 1991). When interviewed several months after
making their decision, parents report that they had been
faced with an extensive amount of information during a
time of considerable anxiety with a resultant feeling of a
lack of control over the situation (Levi et al. 2000). Fur-
thermore, parents report varying levels of choice and par-
ticipation in clinical decision making (Levi et al. 2000),
which suggests the need for a thorough evaluation of the
way in which clinicians recruit participants, the informa-
tion which is provided by medical staff to both the patient
and their parents, and healthcare providers adherence to
the principles of informed consent.
Determining which information to give to parents as
well as the level of involvement they want in their child’s
treatment decisions can be a daunting task for paediatric
oncologists (Nelson & Nelson 1992). Whitney et al. (2006)
present a decisional model which suggests that clinicians
may assume decisional priority when there is a single best
medical choice, but they should encourage parents (and
children when appropriate) to assume decisional priority
when there are two or more clinically reasonable choices.
Although an early study conducted by Pyke-Grimm et al.
(1999) was one of the ﬁrst attempts to ask parents the
type of decision-making cooperation they would prefer,
research is lacking regarding the perceived levels of
involvement different parties have in the selection of a
paediatric cancer treatment regimen. Similarly, parents’
long-term satisfaction with their treatment decisions or
involvement in the decision-making process is under-
researched, giving consultants little insight into how they
can identify the needs of both the patient and their parents
when discussing various courses of treatment.
The current study aimed to identify parental percep-
tions of both their own involvement and that of others in
the decision to enrol their child on to a speciﬁc cancer
treatment protocol and their satisfaction with this deci-
sion. The hypotheses were as follows:
1 If parents do not have the level of involvement they
prefer in deciding on the enrolment of their child in a
treatment protocol, they will have lower satisfaction in
the short and long term.
2 If parents receive too much or too little information
from the medical staff during the decision-making
process, they will have lower satisfaction in the short
and long term.
METHODS
Procedures and measures
This study was approved by the local Ethics Committee.
Parents were recruited from the Paediatric Oncology Unit
of the Queen’s Medical Centre in Nottingham, UK.
Oncologists attained permission from the parents during
or between clinic appointments and ward rounds. The
purpose of the study in the context of examining parental
satisfaction with the treatment decision-making process
was explained to the parents by the oncologist and the
research assistant before written consent was obtained.
The research assistant met with the parents only after the
medical staff obtained their initial verbal consent. The
questionnaires were coded with a respondent number to
protect the identity of the participants, thus ensuring their
conﬁdentiality.
Parents completed an abbreviated form of the Deci-
sional Conﬂict Scale, which is based on decisional conﬂict
in the medical setting regarding cancer screening and vac-
cination uptake (O’Connor 1995). The scale assesses three
main factors including: (1) healthcare consumers’ uncer-
tainty in making a health-related decision; (2) the factors
contributing to the uncertainty; and (3) healthcare con-
sumers’ perceived effectiveness in decision making. The
scale is set at the equivalent of an eighth grade (13–14
years of age) reading level. This is based on a readability
score, the ‘Flesch-Kincaid Grade Level’ score, which rates
text on a US school grade level. Responses are marked on
a Likert scale ranging from 1 (strongly agree) to 5 (strongly
disagree).
The main themes of the scale and the eight questions
subsequently chosen from it for this study, deal with
uncertainty, vacillation, involvement of others, satisfac-
tion and anticipated regret in the decision-making
process. The test–retest reliability of the Decisional Con-
ﬂict Scale in its full form (16 questions) is 0.81, with an
internal consistency rating of 0.78–0.92.
The parents also completed the ‘Responsibility for
Treatment Choice’ Questionnaire whereby they divided a
circle based on how they felt certain parties contributed to
the treatment decision. They were instructed to identify
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622as many people as necessary and divide the circle as many
times that they felt appropriate. A second circle was
divided based on how they would have preferred respon-
sibility for the treatment decision to be distributed. If the
treatment decision process occurred exactly as the parents
desired, they wrote ‘The same’ on the circle. This scale
has been used previously at the recruiting hospital to
assess parent satisfaction in treatment decisions (see
Figs 1 and 2).
The Revised Decisional Conﬂict scale has reverse
scoring, such that higher scores indicate a higher degree of
conﬂict. For the Responsibility for Treatment Choice
Figure 1. The Responsibility for Treatment Choice Questionnaire.
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calculated by the following equation: Adivision = (_/360) ¥
100. Data for the short interview were numerically coded
(e.g. parental satisfaction with their involvement in the
treatment decision process was coded in general levels,
ranging from very dissatisﬁed (1) to very satisﬁed (5).
Previous knowledge and information preferences were
also addressed via four additional questions which were
administered to each parent by the research assistant to
determine:
￿ whether they had heard of paediatric cancer treatments
or research before, and if so, where;
￿ how happy they were with their involvement in their
child’s treatment decision (on a scale of 1–5);
￿ what additional information about treatment options
they would have liked;
￿ how much time (in days) they had to make their
decision.
The answers were noted at the time of the interview.
Demographic data (such as the parents’ age, occupation
and education level) were collected by means of a short
demographic questionnaire.
Data analysis
Data were analysed using the Statistical Package for the
Social Sciences, Version 10.1. The total sample of 66
parents was used in the analysis of the Decisional Conﬂict
Scale, short interview questions and parental demographic
data. To control for the potential weighting of scores from
families in which both parents completed the Responsi-
bility for Treatment Choice Questionnaire, only the
mother’s data were used from the pair for analysis. This
resulted in a sample size of 58 parent–child dyads.
RESULTS
Each of the 66 parents approached consented to take part
in the study and there was no attrition from the study.
Participant demographics
These are presented in Table 1. While all parents of 58
children were invited to take part, mothers were more
likely than fathers to consent and complete the question-
naires. Parents were between 20 and 50 years of age (mean
= 34.18). Their children ranged in age from <1 year to 16.5
years at diagnosis. Thirty parents had children who were
diagnosed within the prior 12 months. The remaining 36
parents had children who were at least 1 year into their
treatment protocol (i.e. 1 year post treatment decision).
The range in time since diagnosis for the entire sample
was 6 weeks to 11 years. Of the 58 children in the study,
30 (51.7%) were still undergoing treatment. The most
common diagnoses were acute lymphoblastic leukaemia
Figure 2. Completed forms for family (a)
and family (b).
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Divide the circle to show how you think the treatment decision was arrived at for your child.
Include anyone who you feel helped influence the decision-making process.
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624(n = 29; 50%), Wilms’ tumour (n = 6; 10.1%), acute myel-
ogenous leukaemia (n = 3; 5.2%) and non-Hodgkin’s lym-
phoma (n = 3; 5.2%). Fifty-ﬁve parents (83.33%) had been
asked to join a treatment trial. Eleven parents (16.67%)
were given treatment options to choose from at the time
of diagnosis, but were not part of a research protocol.
Overall, 49 of the children had been in randomised treat-
ment programmes and 17 on non-randomised protocols.
Previous knowledge and information preferences
Parents reported being happy with their involvement in
their child’s treatment decision (mean 4.48, possible
range: 1–5). Nearly 70% of the parents were content with
the information provided to them at the time of diagnosis.
Nine parents (13.63%) wanted more information about
the medications, three (4.55%) wanted more details about
the trial, one parent wanted more disease-speciﬁc infor-
mation and one mother wanted a better explanation of her
child’s prognosis. The median time available for decision
making as reported by parents was 2.33 days.
Two-thirds of the parents did not know about cancer
treatments or cancer research before their child’s diagno-
sis (n = 41). For those who did know, sources of previous
information were: media (n = 10), families of other chil-
dren with cancer (n = 4), relative/friend (n = 3), a charity
(n = 3), other medical staff (n = 2); and one response each
for school, leaﬂet and newsletter. Individual question
items from the Decisional Conﬂict Scale and Satisfaction
with Involvement are presented in Table 2.
Demographics and participation in decisions
For analysis of the association between parents’ demo-
graphics and their participation, the data from all 66
parents were used. Parents with a higher educational
attainment tended to report that they had a shorter time
frame available to make their decisions (r = 0.249, P <
0.05). Younger parents both received and desired more
family involvement in treatment decisions (r =- 0.299, P <
0.05 for both) while older parents both received and
wanted more input from other medical staff members
(r = 0.258, P < 0.05 and r = 0.260, P < 0.05 respectively).
Correlation analyses
Spearman’s rho correlations were conducted for the Deci-
sional Conﬂict Scale, the Responsibility for Treatment
Choice Questionnaire, parental demographics and satis-
faction with involvement. In partial support of the ﬁrst
hypothesis of the study, parental satisfaction with
involvement was negatively correlated with the Total
Conﬂict Score which was derived from the sum of eight
questions in the Decisional Conﬂict Scale (r =- 0.425, P <
0.01). However, neither the parents’ nor other parties’
level of involvement in the treatment decision correlated
with the parents’ satisfaction with their involvement.
There were also no signiﬁcant correlations between actual
or desired participation and parental satisfaction with
their involvement in the decision-making process. There-
fore, the ﬁrst hypothesis was not fully supported.
Table 1. Demographic data
Variable
Age in years (range, mean)
Parent 20–50 (34.18)
Child 0.83–16.69 (6.04)
Education
Left school at 16 years (no GCSE/CSE
O levels)
11
GCSE/CSE O levels 42
A levels 3
Vocational qualiﬁcation 5
Graduate/postgraduate professional
qualiﬁcation
5
Time since diagnosis (months) (n,% )
<12 30 (45)
12 36 (55)
Diagnosis (n,% )
Acute lymphoblastic leukaemia 29 (50)
Wilms’ tumour 6 (10.1)
Acute myelogenous leukaemia 3 (5.2)
Non-Hodgkin’s lymphoma 3 (5.2)
Other diagnosis 25 (29.5)
Asked to join treatment trial (n, %) 55 (83.33)
Treatment programme (n, % parents)
Randomised 49 (74)
Non-randomised 17 (26)
GCSE/CSE, General Certiﬁcate of Secondary Education/
Certiﬁcated of Secondary Education.
Table 2. Decisional conﬂict scale and satisfaction with involve-
ment scores
Variables n Mean SD
Q1. The decision was hard to make 66 3.39 1.35
Q2. I was unsure what to do in this
decision
66 3.05 1.18
Q3. It was clear which choice was best 66 1.89 1.00
Q4. I felt pressure from others 66 2.02 0.96
Q5. I had the right amount of support from
others
55 1.69 0.71
Q6. Parents should be involved in the
treatment decision
66 1.51 0.75
Q7. I feel I made an informed choice 66 1.71 0.74
Q8. I am satisﬁed with my decision 66 1.44 0.56
Total decision uncertainty (Q1 + Q2 + Q3) 66 8.31 2.37
Total conﬂict (sum of Q1 thru Q8) 66 16.68 3.44
Satisfaction with involvement 66 4.47 0.83
Parental involvement in paediatric cancer treatment decisions
© 2009 The Authors
Journal compilation © 2009 Blackwell Publishing Ltd
625The second hypothesis was supported in that parental
satisfaction with their decision and their involvement in
decision making correlated with the belief that they had
made an informed choice (r = 0.749, P < 0.001 and r =
-0.386, P < 0.01 respectively). Furthermore, parents who
believed the decision was easier to make reported that
they had made an informed choice whereas those who
were unsure which treatment to choose had higher scores
on the Decisional Conﬂict Scale thus reported more dif-
ﬁculty with their decision making (r =- 0.308, P < 0.05 and
r = 0.532, P < 0.001 respectively).
Patterns of decision participation
The mean reported treatment decision participation per-
centages were 62.47% for doctors, 29.42% for parents and
8.11% for children, other family members and healthcare
staff (e.g. nurses and primary care physicians) combined.
On average, the desired participation percentages were
59.30% for doctors, 32.60% for parents and 8.16% for the
others combined. The participation of the doctor in the
decision was negatively related to the input of the parents
(r =- 0.837, P < 0.001), the paediatric patients (r =- 0.383,
P < 0.01) and other medical staff (e.g. nurses; r =- 0.350, P
< 0.01). There was also a trend for a negative association
between the doctor’s participation and that of other family
members (r =- 0.252, P = 0.057).
Decision participation preferences
Paired sample t-tests indicated that individually, parents
preferred to participate more than they were able to, and
that they desired less doctor participation (t(65) =- 2.479,
P < 0.05 and t(65) = 2.396, P < 0.05 respectively) even
though there was only about 3% difference between the
actual and preferred parental and doctoral participation
percentages overall. Parents were more involved in the
decision if they had more time to consider the options (r =
0.390, P < 0.01), while doctors tended to assume the major-
ity of responsibility for decision making in those situa-
tions with minimal time available (r =- 0.322, P < 0.05).
Parents who rated the decision as difﬁcult to make
reported less involvement from doctors (r =- 0.282,
P < 0.05).
Multivariate analyses
Multivariate analyses of variance were conducted to deter-
mine the effect of previous knowledge, trial status, and
the passage of time on parents’ decision-making experi-
ence. Parents who had no previous knowledge of paediat-
ric cancer therapy or clinical trials preferred to have more
involvement in the medical decisions regarding their
child’s treatment (F2,53 = 6.590, P < 0.01). Conversely,
parents with previous knowledge tended to desire more
participation from the oncologist (F2,53 = 3.446, P < 0.05,
least signiﬁcant difference = 0.077). A 2 ¥ 2 analysis of
variance indicated an interaction between parental gender
and previous knowledge of paediatric cancer treatments
for the reported and desired levels of doctor participation
(F1,65 = 5.784, P < 0.05 and F1,65 = 5.456, P < 0.05 respec-
tively). Speciﬁcally, mothers with previous knowledge
reported and preferred more doctor involvement (t(58) =
-2.339, P < 0.05 and t(58) =- 3.147, P < 0.01).
Those who were asked to participate in a non-
randomised protocol reported feeling more pressure from
others (F1,66 = 8.921, P < 0.01; child’s age at diagnosis as
covariate). They also included and desired their child’s
participation in the decision more than those who were
asked to join randomised trials regardless of the child’s age
(F1,58 = 5.546, P < 0.05). Fathers tended to report feeling
more pressure from others and reported more uncertainty
about the optimum choice than did mothers (F1,66 = 3.334,
P = 0.073 and F1,66 = 4.946, P < 0.05 respectively with
child’s age at diagnosis as covariate).
A year after having made a treatment decision, parents
were less sure about which treatment choice was best
(F1,66 = 4.889, P < 0.05 with child’s age at diagnosis as
covariate). Multiple regression analyses were conducted to
determine the predictors of parental satisfaction with
their decision and their involvement. Conﬁdence that
they had made an informed choice, and the degree of
support from others during the decision-making process,
were both important factors in overall parental satisfac-
tion (see Table 3). These ﬁndings supported the study
hypotheses.
DISCUSSION
Participation
Parents believe in the importance of participating in the
decisions affecting the course of their child’s treatment.
However, in the medical setting, doctors often take a
paternalistic position in parent/physician interactions,
and therefore assume most of the power in decision
making (Coulter 1997). Recent research suggests that staff
underestimate the level of involvement and independence
that parents wish to exert on the decision-making process,
and caretaking during a child’s illness (Shields et al. 2004).
Thus, family and doctor roles must be negotiated in
order for optimum co-operation to take place (Thorne &
Robinson 1988).
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626In the current study, parents stated that they would
have preferred more involvement in decisions about treat-
ment than they actually experienced. Not surprisingly,
the oncologist’s involvement decreased when parents
assumed more of the responsibility in deciding upon their
child’s treatment. The doctors tended to have less involve-
ment when the paediatric patient, other family members
and other medical staff where included in the decision.
This difference in involvement could be due to parents
adopting a more active role in medical decision making by
seeking advice from other parties. As a result, the actual
degree of participation for the child, other family members
and other medical staff were essentially the desired degree
of participation because parents had made the decision to
seek their input at the very beginning of the decision-
making process.
Parents who reported less doctor participation also
stated that the decision was more difﬁcult to make. They
also reported more problems with choosing a treatment
when their child and family were included. It is not clear
whether the participation of the other parties made the
decision more difﬁcult or if the parents chose to include
them because they could not decide themselves. For
example, parents reported more pressure from others and
greater child participation in the decision to enter a non-
randomised trial than for those choices that involved ran-
domisation to a treatment protocol. These parents may
have been more likely to include their children in deci-
sions about non-randomised treatments as a method of
reassurance or because it was easier to explain the non-
randomised treatment options to the young patient.
Parents were more involved when they had more time
to make a decision regarding their child’s treatment.
Parents who found themselves with little time to make a
decision may have relegated the decision to the oncologist
in an effort to eliminate the stress of having to choose a
treatment when they were already under the considerable
strain of coping with their child’s cancer diagnosis. When
parents have more time to consider the treatment options
as well as the opinions of others, they may perceive them-
selves as more capable of taking an active role in the
choosing a treatment plan.
Parental age was related to who the parents opted to
include in the decision-making process. Younger parents,
who are arguably less experienced in serious medical
situations, included other family members more often
than their older counterparts. Relatives could provide
these younger parents with the additional information
and support they needed to make the ﬁnal decision.
Conversely, older parents sought out the opinions of
others in the medical community. These parents may
have been more conﬁdent in their decision-making
abilities than younger parents and therefore depended
less on their extended family’s input. They also may
have had more opportunities to interact with different
health professionals in their lifetime, and thus have a
better knowledge of the healthcare system, or even been
raised with the belief that ‘doctor knows best’. This spe-
ciﬁc type of experience could be an incentive to ask a
trusted family physician for advice about entering a
clinical trial instead of relying solely on the opinion of
the oncologist.
Table 3. Regression analyses predicting parental satisfaction and support
Variables entered RR 2 d.f.
F for model R2 change
Parental satisfaction with decision
Informed choice 721*** 0.520 1.64
69.3689 0.520
Parental satisfaction with involvement
Support from others 0.591*** 0.350 1.64
34.4029 0.350
Parental belief of informed choice
Satisfaction with decision 0.721*** 0.520 1.64
69.368 0.520
Support from others 0.765** 0.571 1.64
7.506 0.051
Difﬁculty of decision 0.780* 0.608 1.64
5.848 0.037
Parental report of support from others
Satisfaction with involvement 0.591*** 0.350 1.64
34.402 0.350
Informed choice 0.702*** 0.493 1.64
17.834 0.143
*P < 0.05, **P < 0.01, ***P < 0.001.
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627Parents with prior knowledge of paediatric cancer treat-
ments, particularly the mothers, preferred more involve-
ment from their child’s oncologist. Thus, they may have
sought the professional opinion to a greater degree in an
effort to receive optimum care with fewer side effects.
Conversely, those parents who did not have prior knowl-
edge of what cancer therapies were available wanted to be
more involved in the decisions affecting their children’s
treatment plan. This preference may be due to a ‘closing of
ranks’ following such a serious diagnosis whereby parents
rely solely on their family coping strategies instead of
seeking outside support. To date, little research has been
done on the levels of information patients’ families have
regarding their illness prior to diagnosis. Degner and Sloan
(1992) found, however, that those patients who were
recently diagnosed with cancer needed less involvement
in cancer treatment decisions when compared with the
general public. Thus, those who had attained more disease
and treatment-speciﬁc information (i.e. the patients)
wanted more doctor participation, much like the parents
who had prior knowledge of the details of paediatric
cancer treatments in this study.
Satisfaction
Parents indicated that when there was less conﬂict, they
were more satisﬁed with their choice and their involve-
ment in the decision-making process. ‘Conﬂict’ included
factors such as pressure from others and the clarity of
choice. Parents were happier with their decision when
they felt that they had made an informed choice and
received the right amount of support. In relation to infor-
mation, parents rated support in terms of how willing
medical staff were to give information regarding treat-
ment options.
Perceived support predicted the parents’ satisfaction
with their involvement. The opportunity to discuss treat-
ment options with medical personnel may have helped
alleviate some of the concerns of the parents. Parents
assume responsibility for their child’s health care. Exclu-
sion from the treatment decision-making process would
be in conﬂict with their desired caregiver role (Pinkerton
et al. 1998). Thus, the efforts of medical staff to involve
parents in choosing from different treatment options
would have a favourable outcome on parental satisfaction
as it is consistent with their caregiving role.
The manner in which parents were involved in decision
making also impacted upon their level of satisfaction.
Although their actual degree of participation did not cor-
relate with their overall satisfaction, parents believed that
they should be more involved in their child’s treatment
decisions when it was less evident as to which choice was
best. Reviewing the options and evaluating the risks could
give the parents a sense of control over the health of their
child.
However, the primary evaluation of the positive and
negative aspects of participating in paediatric cancer
research not only affects the parents’ immediate decision,
but could exacerbate the stress that occurs from making
that choice.
Parents found the decision-making process more difﬁ-
cult when they were unsure what to do, indicating that
their assessment of the risks and beneﬁts may remain
unresolved even when they settle upon a choice. Further-
more, parents of children at least 1 year into the treatment
protocol reported that they were still unsure which treat-
ment choice was optimal. Their increased concerns may
have been the result of witnessing the effects of the treat-
ment on their child’s condition and functioning for a
longer period of time. If the parents’ assessment of the
beneﬁts of the treatment became clouded by the occur-
rence of side effects or setbacks, they may have been less
certain that they had made the best treatment choice for
their child.
As parental decision making in the oncology setting has
only begun to be examined in recent years, much research
remains to be done in order to determine which factors
inﬂuence parental satisfaction with this process. For
instance, this study found that information and reassur-
ance provided by the medical staff could be used to predict
the level of parental contentment with the decision-
making experience overall. Parents may have been able to
minimise their decisional conﬂict by receiving the appro-
priate levels of assistance from medical staff and family
members. Consequently, future research should investi-
gate when parents want to be provided with information,
and to what level of detail. Whether parents require infor-
mational or emotional support must be determined in
order to improve the services provided to the families.
Although there were no differences between the satisfac-
tion rates of parents within the ﬁrst 12 months of the
treatment plan and those more than 1 year into the chosen
protocol, there may have been differences in how the
parents evaluated their overall choice based on their
cancer treatment experiences.
Furthermore, the needs of parents may change as their
family progresses through the protocol (Kupst 1993). The
type of information or support required in the early stages
following diagnosis may not be sufﬁcient to help parents
with the difﬁculties that arise later in the treatment
process. A limitation of the cross-sectional methodology
employed in this study is that it cannot specify how the
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628identiﬁed determinants of parental satisfaction change
over time. Interviews with parents throughout their
child’s cancer treatment and follow-up consultations may
help to specify how their needs evolve over time and the
subsequent effect of these upon their satisfaction. Indeed,
taking time to listen to the concerns of families would be
a method of providing support that could improve their
overall satisfaction levels (Goore et al. 2001), and new
mechanisms for achieving this level of care are currently
being trialled, such as videotelephony to improve clinical
and psychosocial support (Bensink et al. 2007). These
basic supportive measures may help lower parental
anxiety regarding their choice and improve the families’
relationship with the medical staff throughout the course
of their children’s care.
Limitations
The main limitations of the study are that reported levels
of parental involvement do not necessarily reﬂect the
actual participation patterns that took place during
the decision-making process. However, the difference
between what parents desire and what they believe they
receive will impact on satisfaction levels. These in turn
can change, but the study was not able to explore how
satisfaction, nor how determinants of parental satisfac-
tion, change over time.
Further research should be carried out into whether the
participation of an increased number of other parties
makes the decision making more difﬁcult or if the parents
chose to include them because they cannot make such
decisions by themselves. If future research examines
which factors inﬂuence parental satisfaction, the current
ﬁndings suggest that a worthwhile area to investigate is
when parents want to be provided with information and at
what level of detail. Last, this may in turn inform, or be
informed by, research examining the impact of differing
levels of information about the illness that patient fami-
lies have prior to their diagnosis.
Implications for practice
There are several important clinical implications of this
study. First, medical staff should be aware that being
asked to take part in a non-randomised trial results in
parents reporting more pressure from others and poten-
tially more stress during the decision-making process.
Furthermore, parents were more involved when they had
more time to make a decision regarding their child’s treat-
ment so, where clinically possible, sufﬁcient time should
be made for parents to consider the options fully. Last, the
willingness of medical staff to provide information was a
key factor in perceived support, which in turn was asso-
ciated with parents’ satisfaction with their involvement
in the decision-making process. Thus medical and nursing
professionals need to ensure that parents know they are
readily available to answer questions and prepared to
provide additional information as required.
Conclusion
A diagnosis of childhood cancer and its subsequent treat-
ment demands provide complex challenges for families as
they attempt to adjust to a ‘new norm’ of family function-
ing. Reassurance from medical staff that the parents’ ques-
tions are important throughout the decision-making
process is crucial to establishing a good working relation-
ship between the medical team and parents which will
last the duration of the child’s treatment.
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